FDA approved APG-1252 as a investigational drug for treatment for small cell on or about Jan 5 2017.
Also PEN-221-001 Somatostatin Reeptor 2 Clinical Trials.gov
Expresses Advance Cancers including Neuroendocrine and Small Cell Lung Cancers
I hope this continues because folks with small cell really need to have new therapies in place. When I here the Gold Treatment is the only treatment gives me pause, hoping for advances in the 2017 that will give all of us suffering from these cancers hope....Kym